Lapatinib Tyverb

Lapatinib Tyverb

This chemotherapy and cancer drugs article is about Lapatinib (Tyverb) which is a biological therapy for treatment of advanced breast cancer, sometimes used with capecitabine or trastuzumab (Herceptin).  It is also used for other cancers.

It is a tyrosine kinase inhibitor that inhibits two specific proteins working - ErbB1 (epidermal growth factor receptor) and ErbB2 (Her2). Lapatinib is taken in tablet form.

Side effects can include: diarrhoea, skin changes, tiredness, soreness and redness in the palms and soles, loss of appetite, indigestion, muscle and joint pain, nausea and vomiting. Rarely there are heart or liver problems.

Approved by

the Medical Board. 

Click Here

 

 

 

 

 

 

Other articles that you may find interesting are:

  1. A diet for Chemotherapy
  2. Immunotherapy overview
  3. A to Z Guide to Complementary Therapies

Go to: Return to the CANCERactive drug list

 

Learn about your cancer drugs.
CancerAcitve Logo
Subscribe (Free e-Newsletter)

Join Our
Newsletter

Join Our Newsletter Signup today for free and be the first to get notified on new updates.